Skip to content
Open access · CC-BY via OpenAlex

Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review

Ronald Winardi Kartika, Veronika Maria Sidharta, Tena Djuartina, Ignatio Rika Haryono, Cynthia Retna Sartika, Kris Herawan Timotius

Bali Medical Journal · 2022 · ▲ 5 citations

Abstract

Umbilical Cord Mesenchyme stem cell (UC-MSCs) /secretome has been applied for treating several diseases, such as cardio-protection and diabetes. Secretome-derived paracrine modulating effects of various growth factors, cytokines, chemokines, angiogenic factors, and exosomes are used in aging therapy. In recent clinical trials on sarcopenia therapy such as pharmaceutical interventions, nutrition, and physical exercise are reported to be effective strategies to reduce sarcopenia. The pathomechanism of the secretome in the treatment of sarcopenia is unclear. This study looked into how secretome might affect myostatin, a biomarker of sarcopenia, at the molecular level. Myostatin, a member of the TGF-family, significantly increases muscle growth when it is absent while suppressing muscle growth when it is present. A bioactive substance called secretome is secreted by MSCs in conditioned conditions. It is rich in growth factors and cytokines, which are crucial for speeding up tissue regeneration. Secretome intervention is a promising approach for treating sarcopenia as showed by its ability to prevent muscle loss and to improve molecular biomarkers.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.15562/bmj.v12i1.3790
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Kartika, R.W., Sidharta, V.M., Djuartina, T., Haryono, I.R., Sartika, C.R., &amp; Timotius, K.H. (2022). Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review. <em>Bali Medical Journal</em>. https://doi.org/10.15562/bmj.v12i1.3790
Vancouver
Kartika RW, Sidharta VM, Djuartina T, Haryono IR, Sartika CR, Timotius KH. Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review. Bali Medical Journal. 2022. doi:10.15562/bmj.v12i1.3790.
BibTeX
@article{ronald2022Roleof, title = {Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review}, author = {Ronald Winardi Kartika and Veronika Maria Sidharta and Tena Djuartina and Ignatio Rika Haryono and Cynthia Retna Sartika and Kris Herawan Timotius}, journal = {Bali Medical Journal}, year = {2022}, doi = {10.15562/bmj.v12i1.3790}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings